Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We have over 15 major partnerships with large and small pharma companies, including Johnson & Johnson (J&J). We provide innovators with a platform to accelerate and de-risk the development of new therapies.

Translational research at the Kennedy Institute is supported by our close collaborations with nearby clinical sites, including the Oxford Experimental Medicine Clinical Research Facility located on the Churchill Hospital site just a ten-minute walk away.

Our partners benefit from access to our cutting-edge in-house technologies. We provide standalone use for specific projects, or customised workflows including multiple technologies, e.g. digital pathology and microbiome analysis, and clinical facilities.

In the software and AI space, we lead the data analysis for several large-scale collaborative projects including the Oxford-J&J Cartography Consortium and the Chan Zuckerberg Initiative LEGACY Network.

We supervise DPhil students sponsored by diverse pharma partners, who therefore gain access to our technologies and collaborations. We support our PIs, students, and postdoctoral researchers to engage in entrepreneurship and technology spin-out.